Tempus AI Net Worth 2023-2025 | TEM
Interactive chart of historical net worth (market cap) for Tempus AI (TEM) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Tempus AI net worth as of August 15, 2025 is $12.82B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.818B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.855B | 58.34 |
| Doximity (DOCS) | United States | $12.199B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $10.401B | 85.22 |
| IRhythm Technologies (IRTC) | United States | $5.159B | 0.00 |
| Hinge Health (HNGE) | United States | $4.608B | 0.00 |
| Privia Health (PRVA) | United States | $2.610B | 193.36 |
| Inspire Medical Systems (INSP) | United States | $2.596B | 38.16 |
| Heartflow (HTFL) | $2.530B | 0.00 | |
| Phreesia (PHR) | United States | $1.708B | 0.00 |
| Enovis (ENOV) | United States | $1.689B | 8.93 |
| 10x Genomics (TXG) | United States | $1.663B | 0.00 |
| Omnicell (OMCL) | United States | $1.456B | 28.04 |
| Schrodinger (SDGR) | United States | $1.426B | 0.00 |
| Azenta (AZTA) | United States | $1.393B | 60.78 |
| Clover Health Investments (CLOV) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.092B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.491B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.429B | 128.00 |
| Carlsmed (CARL) | $0.360B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.360B | 0.00 |
| TruBridge (TBRG) | United States | $0.289B | 50.74 |
| Outset Medical (OM) | United States | $0.236B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.193B | 0.00 |
| CapsoVision (CV) | United States | $0.178B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.110B | 5.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| Pulmonx (LUNG) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |